Develops devices for cardiopulmonary and neuromodulation treatments.
Jun 2026Revenue $1.47B/yrExpenses $1.28B/yr
No trend
Figures by year
Is LivaNova profitable?
Yes. In the 12 months to Jun 2026, revenue was $1.47B and expenses $1.28B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.39B | $1.19B | $199M |
| Dec 2024 | $1.25B | $1.12B | $129M |
| Dec 2023 | $1.15B | $1.22B | −$68.5M |
| Dec 2022 | $1.02B | $1.10B | −$76.8M |
| Dec 2021 | $1.04B | $1.04B | −$784K |
| Dec 2020 | $934M | $1.21B | −$274M |
| Dec 2019 | $1.08B | $1.26B | −$172M |
| Dec 2018 | $1.11B | $1.36B | −$248M |
| Dec 2017 | $1.01B | $916M | $96.5M |
| Dec 2016 | $965M | $931M | $33.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.